XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Treasury Stock, Common [Member]
Beginning Balance at Dec. 31, 2022 $ 48,299 $ 6 $ 369 $ 293,589 $ (245,270) $ (395)
Begining Balance (in shares) at Dec. 31, 2022   565 36,932,177     243,468
Cumulative change in accounting principle (Note 2) (231)       (231)  
Balance as of January 1, 2023 (as adjusted for change in accounting principle) 48,068 $ 6 $ 369 293,589 (245,501) $ (395)
Balance as of January 1, 2023 (as adjusted for change in accounting principle), shares   565 36,932,177     243,468
Issuance of common stock from stock option awards 5     5    
Issuance of common stock from stock options awards, shares     31,191      
Issuance of restricted common stock 152   $ 2 150    
Issuance of restricted common stock, shares     134,592      
Stock-based compensation expense 179     179    
Net Income (Loss) 2,829       2,829  
Ending Balance at Mar. 31, 2023 51,233 $ 6 $ 371 293,923 (242,672) $ (395)
Ending Balance (in shares) at Mar. 31, 2023   565 37,097,960     243,468
Beginning Balance at Dec. 31, 2022 48,299 $ 6 $ 369 293,589 (245,270) $ (395)
Begining Balance (in shares) at Dec. 31, 2022   565 36,932,177     243,468
Net Income (Loss) 5,608          
Ending Balance at Jun. 30, 2023 54,245 $ 6 $ 371 294,156 (239,893) $ (395)
Ending Balance (in shares) at Jun. 30, 2023   563 37,145,151     243,468
Beginning Balance at Mar. 31, 2023 51,233 $ 6 $ 371 293,923 (242,672) $ (395)
Begining Balance (in shares) at Mar. 31, 2023   565 37,097,960     243,468
Issuance of common stock from stock option awards 5     5    
Issuance of common stock from stock options awards, shares     32,111      
Issuance of common stock due to conversion of Series N Preferred stock, shares   (2) 80      
Issuance of restricted common stock, shares     15,000      
Stock-based compensation expense 228     228    
Net Income (Loss) 2,779       2,779  
Ending Balance at Jun. 30, 2023 54,245 $ 6 $ 371 294,156 (239,893) $ (395)
Ending Balance (in shares) at Jun. 30, 2023   563 37,145,151     243,468
Beginning Balance at Dec. 31, 2023 61,080 $ 6 $ 372 294,522 (233,026) $ (794)
Begining Balance (in shares) at Dec. 31, 2023   563 37,157,616     396,175
Issuance of common stock from stock options awards, shares     1,200      
Issuance of restricted common stock (75)   $ 1 (76)    
Issuance of restricted common stock, shares     177,576      
Stock-based compensation expense 228     228    
Net Income (Loss) 1,799       1,799  
Ending Balance at Mar. 31, 2024 63,032 $ 6 $ 373 294,674 (231,227) $ (794)
Ending Balance (in shares) at Mar. 31, 2024   563 37,336,392     396,175
Beginning Balance at Dec. 31, 2023 $ 61,080 $ 6 $ 372 294,522 (233,026) $ (794)
Begining Balance (in shares) at Dec. 31, 2023   563 37,157,616     396,175
Issuance of common stock from stock options awards, shares 13,750          
Net Income (Loss) $ 4,296          
Ending Balance at Jun. 30, 2024 65,813 $ 6 $ 373 294,958 (228,730) $ (794)
Ending Balance (in shares) at Jun. 30, 2024   563 37,341,185     396,175
Beginning Balance at Mar. 31, 2024 63,032 $ 6 $ 373 294,674 (231,227) $ (794)
Begining Balance (in shares) at Mar. 31, 2024   563 37,336,392     396,175
Issuance of common stock from stock option awards (6)     (6)    
Issuance of common stock from stock options awards, shares     4,793      
Stock-based compensation expense 290     290    
Net Income (Loss) 2,497       2,497  
Ending Balance at Jun. 30, 2024 $ 65,813 $ 6 $ 373 $ 294,958 $ (228,730) $ (794)
Ending Balance (in shares) at Jun. 30, 2024   563 37,341,185     396,175